Treatment.com AI announces new additions to its Medical Education Suite (MES)
VANCOUVER, British Columbia, April 17, 2024 – Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is excited to announce two new solutions, (1) AI Patient and (2) AI Doctor in a Pocket, to augment its Medical Education Suite (“MES”) designed to educate the next generation of healthcare providers. Treatment’s MES […]
Treatment.com AI partners with aiXplain Inc. to extend access to its Global Library of Medicine (GLM)
VANCOUVER, British Columbia, April 10, 2024 – Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to announce it has signed a Collaborative Agreement with aiXplain, Inc. (“aiXplain”) to enable greater access to Treatment’s proprietary Global Library of Medicine (“GLM”) by contributing to aiXplain’s ever-growing dynamic Artificial Intelligence (AI) marketplace. Treatment has […]
Treatment.com AI welcomes the Federal Government’s announcement of a plan to fund $2.4 billion in its upcoming budget towards Artificial Intelligence (AI) Adoption
VANCOUVER, British Columbia, April 08, 2024 – Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) welcomes Prime Minister Justin Trudeau’s announcement on 7th April, 2024, that the federal government plans to fund $2.4 billion in its upcoming budget towards build capacity in Artificial Intelligence (AI) adoption. The federal government’s announcement […]
Treatment.com AI Funded by the National Institute of Health to Develop a Culturally Sensitive AI Approach to Health Equity
VANCOUVER, British Columbia, March 27, 2024 – Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is pleased to announce that the Company has received funding from The National Institute of Health (“NIH”) to develop a culturally sensitive AI approach for collecting family medical history. Treatment has partnered with Rush River […]
Treatment.com AI inc. Announces Debt Settlement Transactions
Vancouver, British Columbia, March 21, 2024 – Treatment.com AI Inc. (the “Company” or “Treatment”) (CSE: TRUE; OTC: TREIF; FFA: 939) announces that it proposes to enter into debt settlement agreements with certain arms’ length creditors (the “Creditors”) to settle an aggregate of CAD$461,307.40 in debt (the “Debt”). The Debt relates to outstanding principal and accrued interest on […]
Treatment AI Passes Medical School Clinical Exam with 92% Success Rate
VANCOUVER, British Columbia, March 20, 2024 – Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is pleased to announce that it’s AI medical information support platform was used in the “Objective Structured Clinical Examination” (“OSCE”), a standard clinical exam of diagnostic aptitude at medical and nursing schools, passing the exam […]
Treatment.com AI Inc. Closes over-subscribed non-brokered private placement of $2,908,200
Vancouver, British Columbia, March 14, 2024 – Treatment.com AI Inc. (the “Company” or “Treatment”) (CSE: TRUE; OTC: TREIF; FFA: 939) is pleased to announce that, further to its news release dated February 16, 2024, it has closed a non-brokered private placement of 6,295,500 special warrants of the Company (each, a “Special Warrant”) at a price of $0.40 […]
Treatment.com AI Provides Corporate Update
Bolstering the Leadership Team The Global Library of Medicine Passes Milestone of 1000+ Diseases Treatment Provides Platform to Support Healthcare in Nairobi, Kenya VANCOUVER, British Columbia, February 29, 2024 – Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is pleased to provide a general corporate update. Treatment has been working […]
Treatment.Com International Inc. Announces Closing Of Non-Brokered Private Placement
Vancouver, British Columbia, October 5, 2023 – Treatment.com International Inc. (the “Company” or “Treatment”) (CSE: TRUE; OTC: TREIF; FFA: 939) is pleased to announce, further to its news release on September 28, 2023, the Company has completed its previously announced non-brokered private placement of common shares in the capital of the Company (each, a “Common Share”) at […]
Treatment.Com International Inc. Closes Non-Brokered Private Placement and Debt Settlement
Vancouver, British Columbia, September 29, 2023 – Treatment.com International Inc. (the “Company” or “Treatment”) (CSE: TRUE; OTC: TREIF; FFA: 939) is pleased to announce that further to its news release dated August 18, 2023, the Company has completed the previously announced non-brokered private placement of common shares in the capital of the Company (the “Common Shares”) at […]